Bellagio Sunscreen SPF 30 description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Bellagio Sunscreen SPF 30

Lifetech Resources, LLC

BELLAGIO SUNSCREEN SPRAY SPF 30


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DRUG FACTS

ACTIVE INGREDIENTS

Octocrylene 7.0%, Octinoxate 7.0%, Oxybenzone 6.0%, Octisalate 5.0%

PURPOSE

Sunscreen

USE

Helps prevent sunburn. Higher SPF gives more sunburn protection.

DIRECTIONS FOR USE

Apply evenly and liberally to all exposed areas before sun exposure. Ensure complete coverage. Reapply as needed or after swimming, towel drying, perspiring, or vigorous activity. Ask a doctor before use on children under 6 months of age.

WARNING

For external use only.

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash or irritation develops and lasts.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

INACTIVE INGREDIENTS

Caprylic/Capric Triglyceride, Cyclopentasiloxane, VP/Hexadecene Copolymer, Retinyl Palmitate, Tocopheryl Acetate, Tetrahexyldecyl Ascorbate.

PRINCIPAL DISPLAY PANEL - 237 ML Bottle Label

BELLAGIO ®

SUNSCREEN
SPRAY

SPF 30

8 FL OZ / 237 ML

Bellagio Sunscreen SPF 30

Bellagio Sunscreen SPF 30

Octinoxate, Octocrylene, Oxybenzone, and Octisalate SPRAY

Product Information

Product Type Human otc drug label Item Code (Source) NDC:65643-329
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 68.32 mg
OCTOCRYLENE Octocrylene 68.32 mg
OXYBENZONE OXYBENZONE 58.56 mg
OCTISALATE OCTISALATE 48.8 mg

Inactive Ingredients

Ingredient Name Strength
MEDIUM-CHAIN TRIGLYCERIDES
CYCLOMETHICONE 5
VITAMIN A PALMITATE
.ALPHA.-TOCOPHEROL ACETATE, D-

Product Characteristics

Color
YELLOW

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:65643-329-11 237 in 1 BOTTLE, SPRAY

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2009-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.